Table 1.
Discovery cohort | Verification cohort | |||
---|---|---|---|---|
Healthy controls (n = 12) | RCC patients (n = 12) | Healthy controls (n = 50) | RCC patients (n = 130) | |
Age, years (median) | 29–78 (64) | 36–79 (62) | 48–76 (66) | 27–83 (64) |
Gender, male/female | 9/3 | 9/3 | 39/11 | 95/35 |
Hb, g/dL (median) | 11.0–15.5 (14.0) | 9.2–16.2 (12.9) | 12.0–17.6 (14.2) | 4.9–17.4 (13.6) |
CRP, mg/dL (median) | 0–0.05 (0) | 0–13.94 (0.28) | 0–0.69 (0) | 0–19.86 (0.05) |
NLR (median) | 0.93–3.97 (1.78) | 1.15–5.87 (1.95) | 0.83–12.23 (1.96) | 0.87–9.68 (2.46) |
TNM stage, I/II/III/IV | 6/0/4/2 | 78/9/26/17 | ||
Histological type | ||||
Clear cell | 11 | 111 | ||
Papillary | 1 | 7 | ||
Chromophobe | 0 | 6 | ||
Unclassified | 0 | 6 |
Hb, hemoglobin; CRP, C‐reactive protein; NLR, neutrophil to lymphocyte ratio.